Frontlight ResearchEarly access
Dilated cardiomyopathy trials in United States
9 of 17 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
- Where
- Baltimore, Birmingham, Boston, Chicago, Cincinnati, Columbus, Detroit, Durham, Houston, Jacksonville, Kansas City, Los Angeles, Minneapolis, Nashville, New Orleans, New York, Omaha, Philadelphia, Portland, Rochester, San Diego, San Francisco, Stanford, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Kardigan, Inc.
See details and how to joinNCT07210723 - Phase 3Taking peopleA Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
- Where
- Baltimore, Birmingham, Boston, Chicago, Cincinnati, Columbus, Detroit, Durham, Houston, Jacksonville, Kansas City, Los Angeles, Minneapolis, Nashville, New Orleans, New York, Omaha, Philadelphia, Portland, Rochester, San Diego, San Francisco, Stanford, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Kardigan, Inc.
See details and how to joinNCT07771465 - Phase 1/2Taking peopleAn AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
- Where
- Houston, Kansas City, Miami, New York
- Age
- 18 years to 70 years
- People
- 22 worldwide
- Run by
- Affinia Therapeutics
See details and how to joinNCT07426419 - Phase 1Taking peopleA Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
- Where
- Charleston, Rochester, San Diego
- Age
- 18 years to 65 years
- People
- 8
- Run by
- Rocket Pharmaceuticals Inc.
See details and how to joinNCT07137338 - Phase 1/2Taking peopleALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
- Where
- Birmingham, Boston, Cincinnati, Houston, Palo Alto, Philadelphia, Portland
- Age
- 18 years to 70 years
- People
- 6 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07218887 · EU 2024-519674-40-00 - Phase 1/2Taking peopleA Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)
- Where
- Ann Arbor, Birmingham, Boston, Cincinnati, Columbus, Houston, Los Angeles, Rochester
- Age
- 18 years and over
- People
- 21
- Run by
- Nuevocor Pte. Ltd.
See details and how to joinNCT07606274 · EU 2025-524828-21-00 - Phase 1Taking peopleA Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM)
- Where
- Atlanta
- Age
- 4 years to 40 years
- People
- 36
- Run by
- Emory University
See details and how to joinNCT06464588 - Phase 1Taking peopleModulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy
- Where
- Cincinnati, Columbus, Kansas City
- Age
- 18 years and over
- People
- 12
- Run by
- Sardocor Corp.
See details and how to joinNCT06224660 - No phaseTaking peopleDilated Cardiomyopathy Detection Using AI and Screening With Mobile Technology (DCM-DETECT)
- Where
- Lancaster
- Age
- 18 years and over
- People
- 150
- Run by
- Lancaster General Hospital
See details and how to joinNCT06688396